Disseminated Strongyloidiasis.
Mileo Bacelar Guerreiro F, Tavares Sodré C, Brandão Pavan L, Feijó Barroso P, Carvalho Quintella D, Cuzzi T, Ramos-E-Silva M.
Acta Dermatovenerol Croat. 2018 Dec;26(4):333-336.
Strongyloidiasis.
Gordon CA, Utzinger J, Muhi S, Becker SL, Keiser J, Khieu V, Gray DJ.
Nat Rev Dis Primers. 2024 Jan 25;10(1):6. doi: 10.1038/s41572-023-00490-x.
Disseminated strongyloidiasis.
Cappello M, Hotez PJ.
Semin Neurol. 1993 Jun;13(2):169-74. doi: 10.1055/s-2008-1041122.
Strongyloidiasis: A Neglected Tropical Disease.
Krolewiecki A, Nutman TB.
Infect Dis Clin North Am. 2019 Mar;33(1):135-151. doi: 10.1016/j.idc.2018.10.006.
Human strongyloidiasis: complexities and pathways forward.
Buonfrate D, Bradbury RS, Watts MR, Bisoffi Z.
Clin Microbiol Rev. 2023 Dec 20;36(4):e0003323. doi: 10.1128/cmr.00033-23. Epub 2023 Nov 8.
Fatal Disseminated Strongyloidiasis in Steroid Overuse.
Rajakumar P, D'Cruze L, Ganesh P, Mahadevan S.
JCEM Case Rep. 2023 Feb 1;1(1):luad004. doi: 10.1210/jcemcr/luad004. eCollection 2023 Jan.
Disseminated strongyloidiasis after prolonged treatment with corticosteroids.
Mahoney C, Brown CM, McIntyre B, Neal S.
BMJ Case Rep. 2022 Jul 14;15(7):e250559. doi: 10.1136/bcr-2022-250559.
Disseminated Strongyloidiasis: Breaking Brain Barriers.
Sebastian IA, Pandian JD, Oberoi A, Kate MP, Jaison V, Bose S, Sahonta R, Nagpal S, Brar I.
Ann Indian Acad Neurol. 2019 Apr-Jun;22(2):234-237. doi: 10.4103/aian.AIAN_321_18.
Clinical Characteristics of Disseminated Strongyloidiasis, Japan, 1975-2017.
Mukaigawara M, Narita M, Shiiki S, Takayama Y, Takakura S, Kishaba T.
Emerg Infect Dis. 2020 Mar;26(3):401-408. doi: 10.3201/eid2603.190571.
From strongyloidiasis to disseminated mucormycosis: the story of an HTLV-1-infected migrant.
Autier B, Chesnay A, Mayence C, Houcke S, Guégan H, Demar M, Blanchet D.
J Travel Med. 2021 Aug 27;28(6):taaa229. doi: 10.1093/jtm/taaa229.
